OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
104
Views
14
CrossRef citations to date
0
Altmetric
Original Research
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
Liang Huang1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
, Qi Liu2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;3 Department of Radiation Oncology, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China
, Sheng Chen1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
& Zhiming Shao1 Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaCorrespondence[email protected]
Pages 5739-5744
|
Published online: 01 Dec 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.